Suven Pharma trades 2% up on open offer for 6.61 crore shares
The price offered of Rs 495 to public shareholders is at a discount of Rs 79 to the current market price.11-10-2023
11-10-2023
Suven Pharmaceuticals Ltd - 543064 - Letter of Offer
Kotak Mahindra Capital Company Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer for the attention of the public shareholders of Suven Pharmaceuticals Ltd ("Target Company").11-10-2023
Suven Pharmaceuticals Ltd - 543064 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI LODR, this to inform you that the Company has received intimation from the RTA regarding loss of share certificate, details are as per letter attached.04-10-2023
Suven Pharmaceuticals Ltd - 543064 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DB Trustees (Hong Kong) Ltd04-10-2023
Suven Pharmaceuticals Ltd - 543064 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter and half year ended 30th September 2023.03-10-2023
Suven Pharmaceuticals Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property & Equity Holdings Pvt Ltd03-10-2023
Suven Pharmaceuticals Ltd - 543064 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Berhyanda Ltd & PACs03-10-2023
Suven Pharmaceuticals Ltd - 543064 - Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Berhyanda Ltd & PACs03-10-2023
Suven Pharmaceuticals Ltd - 543064 - Closure of Trading Window
We wish to inform you that the "Trading Window" for dealing in the Securities of the Company be closed for the Designated Person, their immediate relatives covered under the said Code of the Company from 1st October, 2023 and the same will remian closed till 48 hours after the declaration of Financial Results for the quarter ending 30th September 2023, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.30-09-2023
Suven Pharmaceuticals Ltd - 543064 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September 30, 2023 for Jasti Property and Equity Holdings Pvt Ltd & Venkateswarlu Jasti30-09-2023